Nasopharyngeal Carcinoma in Children: Clinicopathological Features and Survival Outcomes
New research conducted by the School of Medicine at Huzhou University reveals crucial insights into the clinicopathological features and survival outcomes of nasopharyngeal cancer (NPC) in children and adolescents. The study utilized the Surveillance, Epidemiology, and End Results database to analyze demographic and clinicopathological variables of pediatric patients diagnosed with NPC between 2000 and 2018. The research highlights the significance of TNM stage and radiotherapy as predictors of overall survival in pediatric NPC patients.
Key Takeaways:
- The study analyzed a cohort of 233 pediatric patients diagnosed with NPC, with a median age at diagnosis of 16 years (range: 7-19 years).
- Nasopharyngeal cancer primarily affected males, with 70.0% of the patients being male.
- The cancers were predominantly undifferentiated, with 134 (57.5%) patients having undifferentiated cancer, followed by poorly differentiated cancer (13.3%), and well and moderately differentiated cancer (3.5%).
- TNM stage and radiotherapy were significant independent predictors of overall survival in pediatric NPC patients.
- The risk of death was higher for M1 stage compared to other stages, with a hazard ratio of 20.1 (95% confidence interval: 8.0-50.5; p < 0.001).
- The study highlights the importance of studying NPC in children independently, as it is a rare condition.
- The research emphasizes the need for early detection and treatment of pediatric NPC, particularly in terms of radiotherapy.
Statistics:
- 70.0% of pediatric patients diagnosed with NPC were male.
- 134 (57.5%) patients had undifferentiated NPC.
- 31 (13.3%) patients had poorly differentiated NPC.
- 8 (3.5%) patients had well and moderately differentiated NPC.
- The hazard ratio of death for M1 stage was 20.1 (95% confidence interval: 8.0-50.5; p < 0.001).
- The study analyzed 233 pediatric patients diagnosed with NPC between 2000 and 2018.
Sources:
- Prognosis of nasopharyngeal carcinoma in children and adolescents: a population-based analysis. BMC Pediatrics, 2025,25(1):1-7. (BMC Pediatrics - https://bmcpediatr.biomedcentral.com)
- Surveillance, Epidemiology, and End Results database (2000-2018)
- Huzhou University
- Yi Shi, School of Medicine, Huzhou university
- Yang Wu, Jiezhi He, Yinjie Ling, Wenyuan Liu